UCB SA
UCBBiotechnology
€280.00+3.51%As of Oct 29vs prior close
- Market cap
- $59.4B
- P/E (TTM)
- 25.6×
- P/E (FY1)
- 22.3×
- From 52W high
- −1.27%
- EPS (LTM)
- €11.32
- Revenue (LTM)
- €8.5B
- Net margin
- 25.74%
- Dividend yield
- 0.52%
Nomior Score
56
Steady ProfileTop 36% of the scored universe
Growth61
Quality64
Value61
Momentum37
Resilience46
Growth
+11.95%revenue a year over 3 fiscal years
YE22 €5.5BLTM €8.5B
Connections
Revenue to profitYE25
20% of revenue became net profit, up 3 pts on a year.